Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions

Amorphous solid dispersions (ASDs) are important formulation strategies for improving the dissolution process and oral bioavailability of poorly soluble drugs. Physical stability of a candidate drug must be clearly understood to design ASDs with superior properties. The crystallization tendency of s...

Full description

Saved in:
Bibliographic Details
Main Author: Kohsaku Kawakami (Author)
Format: Book
Published: MDPI AG, 2019-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d6ad1e55b4744f9cb4009a76d7fef92a
042 |a dc 
100 1 0 |a Kohsaku Kawakami  |e author 
245 0 0 |a Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions 
260 |b MDPI AG,   |c 2019-05-01T00:00:00Z. 
500 |a 1999-4923 
500 |a 10.3390/pharmaceutics11050202 
520 |a Amorphous solid dispersions (ASDs) are important formulation strategies for improving the dissolution process and oral bioavailability of poorly soluble drugs. Physical stability of a candidate drug must be clearly understood to design ASDs with superior properties. The crystallization tendency of small organics is frequently estimated by applying rapid cooling or a cooling/reheating cycle to their melt using differential scanning calorimetry. The crystallization tendency determined in this way does not directly correlate with the physical stability during isothermal storage, which is of great interest to pharmaceutical researchers. Nevertheless, it provides important insights into strategy for the formulation design and the crystallization mechanism of the drug molecules. The initiation time for isothermal crystallization can be explained using the ratio of the glass transition and storage temperatures (<i>T<sub>g</sub></i>/<i>T</i>). Although some formulation processes such as milling and compaction can enhance nucleation, the <i>T<sub>g</sub></i>/<i>T</i> ratio still works for roughly predicting the crystallization behavior. Thus, design of accelerated physical stability test may be possible for ASDs. The crystallization tendency during the formulation process and the supersaturation ability of ASDs may also be related to the crystallization tendency determined by thermal analysis. In this review, the assessment of the crystallization tendency of pharmaceutical glasses and its relevance to developmental studies of ASDs are discussed. 
546 |a EN 
690 |a pharmaceutical glass 
690 |a crystallization tendency 
690 |a crystallization 
690 |a nucleation 
690 |a milling 
690 |a accelerated stability test 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 11, Iss 5, p 202 (2019) 
787 0 |n https://www.mdpi.com/1999-4923/11/5/202 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/d6ad1e55b4744f9cb4009a76d7fef92a  |z Connect to this object online.